The role of radiation therapy in the treatment of glomus jugulare tumors
- 1 July 1978
- Vol. 42 (1) , 104-106
- https://doi.org/10.1002/1097-0142(197807)42:1<104::aid-cncr2820420117>3.0.co;2-w
Abstract
The records of 14 patients who received irradiation for incompletely excised, inoperable or recurrent glomus jugulare tumors were retrospectively reviewed. Ages ranged from 12 to 66 years, and the male to female ratio was 1:3. With a follow-up time of 1.3 to 17.2 years (mean of 7.7 years), 11/14 remain clinically disease-free. Doses of at least 4000 rad are shown to be effective in controlling glomus jugulare tumors.This publication has 10 references indexed in Scilit:
- Chemodectomas Involving the Temporal BoneRadiology, 1975
- Chemodectomas of the Middle Ear: A Comparison of Therapeutic ModalitiesJAMA Otolaryngology–Head & Neck Surgery, 1973
- RADIATION THERAPY OF THE GLOMUS JUGULARE TUMORAmerican Journal of Roentgenology, 1973
- Radiotherapy of Tympanojugular OhemodectomasRadiology, 1972
- Chemodectomas of the glomus jugulareCancer, 1972
- XLVII Current Management Glomus Jugulare TumorsAnnals of Otology, Rhinology & Laryngology, 1967
- The role of radiation therapy in the treatment of chemodectomas of the glomus jugulareThe Laryngoscope, 1965
- Glomus jugulare and carotid body tumoursClinical Radiology, 1961
- XCII The Glomus Jugulare, a Nonchromaffin Paraganglion, in ManAnnals of Otology, Rhinology & Laryngology, 1953
- CAROTID BODY TUMOR OF THE MIDDLE EAR AND MASTOIDJAMA Otolaryngology–Head & Neck Surgery, 1945